跳轉至內容
Merck
  • Chondroitin sulfate E blocks enzymatic action of heparanase and heparanase-induced cellular responses.

Chondroitin sulfate E blocks enzymatic action of heparanase and heparanase-induced cellular responses.

Biochemical and biophysical research communications (2019-10-05)
Nobuaki Higashi, Rino Maeda, Nakaba Sesoko, Momoko Isono, Sodai Ishikawa, Yurina Tani, Katsuhiko Takahashi, Teruaki Oku, Kyohei Higashi, Shoichi Onishi, Motowo Nakajima, Tatsuro Irimura
摘要

We examined whether chondroitin sulfates (CSs) exert inhibitory effects on heparanase (Hpse), the sole endoglycosidase that cleaves heparan sulfate (HS) and heparin, which also stimulates chemokine production. Hpse-mediated degradation of HS was suppressed in the presence of glycosaminoglycans derived from a squid cartilage and mouse bone marrow-derived mast cells, including the E unit of CS. Pretreatment of the chondroitin sulfate E (CS-E) with chondroitinase ABC abolished the inhibitory effect. Recombinant proteins that mimic pro-form and mature-form Hpse bound to the immobilized CS-E. Cellular responses as a result of Hpse-mediated binding, namely, uptake of Hpse by mast cells and Hpse-induced release of chemokine CCL2 from colon carcinoma cells, were also blocked by the CS-E. CS-E may regulate endogenous Hpse-mediated cellular functions by inhibiting enzymatic activity and binding to the cell surface.